{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:59:03Z","timestamp":1794855543397,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011997","name":"Fundaci\u00f3n SEEN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-023-00618-w","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T03:01:52Z","timestamp":1705374112000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry"],"prefix":"10.1007","volume":"31","author":[{"given":"Paola","family":"Parra Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mart\u00edn Rojas-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Paja Fano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Gonz\u00e1lez-Boillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eider","family":"Pascual-Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Garc\u00eda Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Gabriel","family":"Ruiz-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Vicente Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"G\u00f3mez Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Garc\u00eda Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Recasens Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Barahona San Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Pic\u00f3n C\u00e9sar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"D\u00edaz Guardiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina M.","family":"Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Manj\u00f3n-Migu\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Rebollo Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Robles L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morales-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Calatayud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Andree Furio Collao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Antonio","family":"Sampedro-Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mena Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Sanmart\u00edn S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Gonzalvo Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Guerrero-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Castillo Tous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Serrano Gotarredona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Michalopoulou Alevras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ten\u00e9s Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Roa Chamorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Jaen Aguila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Mar\u00eda","family":"Moya Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia A.","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"issue":"1","key":"618_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41\u201350. https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4. (Epub 2017 Nov 9 PMID: 29129575).","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"618_CR2","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98(12):4826\u201333. https:\/\/doi.org\/10.1210\/jc.2013-2805. (Epub 2013 Sep 20 PMID: 24057288).","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"618_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u2013916. https:\/\/doi.org\/10.1210\/jc.2015-4061. (Epub 2016 Mar 2 PMID: 26934393).","journal-title":"J Clin Endocrinol Metab"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","volume":"3","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol. 2018;3:768\u201374. https:\/\/doi.org\/10.1001\/jamacardio.2018.2003.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"618_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1530\/EJE-21-0018","volume":"185","author":"A K\u00f6hler","year":"2021","unstructured":"K\u00f6hler A, Sarkis AL, Heinrich DA, M\u00fcller L, Handgriff L, Deniz S, Schneider H, K\u00fcnzel H, Ladurner R, Reincke M, Adolf C. Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study. Eur J Endocrinol. 2021;185(5):663\u201372. https:\/\/doi.org\/10.1530\/EJE-21-0018. (PMID: 34468397).","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"618_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-21-0836","volume":"186","author":"VC Wu","year":"2021","unstructured":"Wu VC, Wang SM, Huang KH, Tsai YC, Chan CK, Yang SY, Lin LY, Chang CC, Lu CC, Lin YH, Chen YM, Chueh JS. Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments. Eur J Endocrinol. 2021;186(2):195\u2013205. https:\/\/doi.org\/10.1530\/EJE-21-0836. (PMID: 34851859).","journal-title":"Eur J Endocrinol"},{"key":"618_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/AJH\/HPAD032","author":"A Mansur","year":"2023","unstructured":"Mansur A, Vaidya A, Turchin A. Using renin activity to guide mineralocorticoid receptor antagonist therapy in patients with low renin and hypertension. Am J Hypertens. 2023. https:\/\/doi.org\/10.1093\/AJH\/HPAD032.","journal-title":"Am J Hypertens"},{"issue":"13","key":"618_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.916744.PMID:35846272;PMCID:PMC9279860","volume":"30","author":"TH Puar","year":"2022","unstructured":"Puar TH, Cheong CK, Foo RSY, Saffari SE, Tu TM, Chee MR, Zhang M, Ng KS, Wong KM, Wong A, Ng FC, Aw TC, Khoo J, Gani L, King T, Loh WJ, Soh SB, Au V, Tay TL, Tan E, Mae L, Yew J, Tan YK, Tong KL, Lee S, Chai SC. Treatment of primary aldosteronism and reversal of renin suppression improves left ventricular systolic function. Front Endocrinol (Lausanne). 2022;30(13): 916744. https:\/\/doi.org\/10.3389\/fendo.2022.916744.PMID:35846272;PMCID:PMC9279860.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"9","key":"618_CR9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1161\/HYPERTENSIONAHA.123.21096","volume":"80","author":"S Katsuragawa","year":"2023","unstructured":"Katsuragawa S, Goto A, Shinoda S, Inoue K, Nakai K, Saito J, Nishikawa T, Tsurutani Y. Association of reversal of renin suppression with long-term renal outcome in medically treated primary aldosteronism. Hypertension. 2023;80(9):1909\u201320. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21096. (Epub 2023 Jul 14 PMID: 37449450).","journal-title":"Hypertension"},{"issue":"13","key":"618_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023813","volume":"11","author":"T Ueda","year":"2022","unstructured":"Ueda T, Tsurutani Y, Osada J, Inoue K, Hoshino Y, Ono M, Nakai K, Saito J, Yumoto K, Nishikawa T. Comparison of echocardiographic changes between surgery and medication treatment in patients with primary aldosteronism. J Am Heart Assoc. 2022;11(13): e023813. https:\/\/doi.org\/10.1161\/JAHA.121.023813. (Epub 2022 Jun 29. PMID: 35766291; PMCID: PMC9333367).","journal-title":"J Am Heart Assoc"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:51\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(17)30367-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"618_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41440-022-01045-5","volume":"46","author":"Y Yoshida","year":"2023","unstructured":"Yoshida Y, Fujiki R, Kinoshita M, Sada K, Miyamoto S, Ozeki Y, Mori Y, Matsuda N, Noguchi T, Nakama H, Okamoto M, Gotoh K, Masaki T, Shibata H. Importance of dietary salt restriction for patients with primary aldosteronism during treatment with mineralocorticoid receptor antagonists: the potential importance of post-treatment plasma renin levels. Hypertens Res. 2023;46(1):100\u20137. https:\/\/doi.org\/10.1038\/s41440-022-01045-5. (Epub 2022 Oct 14 PMID: 36229529).","journal-title":"Hypertens Res"},{"issue":"11","key":"618_CR13","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1210\/jc.2016-1963","volume":"101","author":"R Baudrand","year":"2016","unstructured":"Baudrand R, Guarda FJ, Torrey J, Williams G, Vaidya A. Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism. J Clin Endocrinol Metab. 2016;101(11):3989\u201396. https:\/\/doi.org\/10.1210\/jc.2016-1963.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"618_CR14","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1530\/EJE-22-0375","volume":"187","author":"SY Chen","year":"2022","unstructured":"Chen SY, Chen JY, Huang WC, Puar THK, Chin Kek P, Chueh JS, Lin YH, Wu VC, Study Group T. Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis. Eur J Endocrinol. 2022;187(6):S47\u201358. https:\/\/doi.org\/10.1530\/EJE-22-0375. (PMID: 36315466).","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"618_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12020-022-03122-8","volume":"78","author":"M Araujo-Castro","year":"2022","unstructured":"Araujo-Castro M, Paja Fano M, Gonz\u00e1lez Boillos M, Pla Peris B, Pascual-Corrales E, Garc\u00eda Cano AM, Parra Ram\u00edrez P, Rojas-Marcos PM, Ruiz-Sanchez JG, Vicente Delgado A, G\u00f3mez Hoyos E, Ferreira R, Garc\u00eda Sanz I, Recasens Sala M, Barahona San Millan R, Pic\u00f3n C\u00e9sar MJ, D\u00edaz Guardiola P, Garc\u00eda Gonz\u00e1lez JJ, Perdomo CM, Manj\u00f3n Migu\u00e9lez L, Garc\u00eda Centeno R, Percovich JC, Rebollo Rom\u00e1n \u00c1, Gracia Gimeno P, Robles L\u00e1zaro C, Morales-Ruiz M, Hanzu FA. Adrenal venous sampling in primary aldosteronism: experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register). Endocrine. 2022;78(2):363\u201372. https:\/\/doi.org\/10.1007\/s12020-022-03122-8.","journal-title":"Endocrine"},{"issue":"3","key":"618_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s12020-022-03029-4","volume":"76","author":"M Araujo-Castro","year":"2022","unstructured":"Araujo-Castro M, Paja Fano M, Gonz\u00e1lez Boillos M, Pla Peris B, Pascual-Corrales E, Garc\u00eda Cano AM, Parra Ram\u00edrez P, Rojas-Marcos PM, Ruiz-Sanchez JG, Vicente Delgado A, G\u00f3mez Hoyos E, Ferreira R, Garc\u00eda Sanz I, D\u00edaz Guardiola P, Garc\u00eda Gonz\u00e1lez JJ, Perdomo CM, Morales M, Hanzu FA. Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry. Endocrine. 2022;76(3):687\u201396. https:\/\/doi.org\/10.1007\/s12020-022-03029-4. (Epub 2022 Mar 11 PMID: 35275344).","journal-title":"Endocrine"},{"issue":"9","key":"618_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M, Primary Aldosteronism Surgery Outcome (PASO) investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5(9):689\u201399. https:\/\/doi.org\/10.1016\/S2213-8587(17)30135-3. (Epub 2017 May 30. PMID: 28576687; PMCID: PMC5572673).","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"618_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3275\/7611","volume":"35","author":"G Bernini","year":"2012","unstructured":"Bernini G, Bacca A, Carli V, Carrara D, Materazzi G, Berti P, Miccoli P, Pisano R, Tantardini V, Bernini M, Taddei S. Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment. J Endocrinol Investig. 2012;35(3):274\u201380. https:\/\/doi.org\/10.3275\/7611. (Epub 2011 Mar 21 PMID: 21422805).","journal-title":"J Endocrinol Investig"},{"issue":"7","key":"618_CR19","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1245\/s10434-013-2871-3","volume":"20","author":"GA Kline","year":"2013","unstructured":"Kline GA, Pasieka JL, Harvey A, So B, Dias VC. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes. Ann Surg Oncol. 2013;20(7):2274\u20138. https:\/\/doi.org\/10.1245\/s10434-013-2871-3.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"618_CR20","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1210\/clinem\/dgac539","volume":"107","author":"VC Wu","year":"2022","unstructured":"Wu VC, Peng KY, Hu YH, Chang CC, Chan CK, Lai TS, Lin YH, Wang SM, Lu CC, Liu YC, Tsai YC, Chueh JS. Circulating plasma concentrations of ACE2 in primary aldosteronism and cardiovascular outcomes. J Clin Endocrinol Metab. 2022;107(12):3242\u201351. https:\/\/doi.org\/10.1210\/clinem\/dgac539. (PMID:36125178;PMCID:PMC9494503).","journal-title":"J Clin Endocrinol Metab"},{"issue":"10285","key":"618_CR21","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","volume":"397","author":"BPLTT Collaboration","year":"2021","unstructured":"Collaboration BPLTT. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(21)00590-0. (Erratum.In:Lancet.2021May22;397(10288):1884).","journal-title":"Lancet"},{"issue":"9","key":"618_CR22","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/s41440-022-00960-x","volume":"45","author":"M Nomura","year":"2022","unstructured":"Nomura M, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Inagaki N, Yamamoto K, Otsuki M, Yabe D, Izawa S, Takahashi Y, Suzuki T, Yasoda A, Tanabe A, Naruse M, JPAS\/JRAS Study Group. Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism. Hypertens Res. 2022;45(9):1476\u201385. https:\/\/doi.org\/10.1038\/s41440-022-00960-x. (Epub 2022 Jun 28. PMID: 35764671).","journal-title":"Hypertens Res"},{"issue":"2","key":"618_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/1570161114666151202210221","volume":"14","author":"A Gulati","year":"2016","unstructured":"Gulati A. Vascular endothelium and hypovolemic shock. Curr Vasc Pharmacol. 2016;14(2):187\u201395. https:\/\/doi.org\/10.2174\/1570161114666151202210221.","journal-title":"Curr Vasc Pharmacol"},{"issue":"4","key":"618_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ehj.2003.10.030","volume":"25","author":"R Latini","year":"2004","unstructured":"Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, Barlera S, Maggioni AP, Tognoni G, Cohn JN, Val-HeFT Investigators. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004;25(4):292\u20139. https:\/\/doi.org\/10.1016\/j.ehj.2003.10.030. (PMID: 14984917).","journal-title":"Eur Heart J"},{"issue":"21","key":"618_CR25","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/eurheartj\/ehm399","volume":"28","author":"NI Parikh","year":"2007","unstructured":"Parikh NI, Gona P, Larson MG, Wang TJ, Newton-Cheh C, Levy D, Benjamin EJ, Kannel WB, Vasan RS. Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J. 2007;28(21):2644\u201352. https:\/\/doi.org\/10.1093\/eurheartj\/ehm399. (Epub 2007 Sep 25 PMID: 17895253).","journal-title":"Eur Heart J"}],"container-title":["High Blood Pressure &amp; Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-023-00618-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-023-00618-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-023-00618-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T18:49:20Z","timestamp":1710355760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-023-00618-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s40292-023-00618-w","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"28 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Hospital Universitario Ram\u00f3n y Cajal. Madrid. Spain (approval date: 10th November 2020, code: ACTA 401)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Patient consent was waived due to the retrospective nature of the study. Only for patients who continued follow-up or prospectively included the informed consent was requested.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}